本間 康一郎

Medicine & Life Sciences

1. Kidney 100%
2. rho-Associated Kinases 80%
3. Chronic Renal Insufficiency 67%
4. Arterioles 65%
5. Hydrogen 52%
6. Microcirculation 45%
7. Lipoproteins 43%
8. LDL Lipoproteins 42%
9. Inhalation 42%
10. Renal Dialysis 40%
11. Gases 38%
12. dimethylargininase 32%
13. Human Embryonic Stem Cells 31%
14. fasudil 31%
15. Inbred SHR Rats 29%
16. Constriction 29%
17. efonidipine 29%
18. Angiotensin II 27%
19. Nitric Oxide 27%
20. N,N-dimethylarginine 27%
21. Pioglitazone 26%
22. Proteinuria 25%
23. Blood Pressure 25%
24. Mibefradil 24%
25. oxidized low density lipoprotein 24%
26. remnant-like particle cholesterol 23%
27. Dilatation 23%
28. Wounds and Injuries 23%
29. Vasodilation 21%
30. Nephrectomy 21%
31. Acute Kidney Injury 21%
32. trandolapril 21%
33. Endothelial Cells 20%
34. Hypertension 20%
35. LDL Cholesterol 19%
36. lipoprotein cholesterol 19%
37. HDL Lipoproteins 19%
38. Coronavirus 18%
39. Induced Pluripotent Stem Cells 18%
40. Losartan 18%
41. Peroxisome Proliferator-Activated Receptors 17%
42. Vascular System Injuries 17%
43. Nifedipine 17%
44. Triglycerides 17%
45. Acetylcholine 17%
46. Maintenance 16%
47. Blood Vessels 16%
48. Angiotensin Receptor Antagonists 16%
49. candesartan 15%
50. Therapeutics 15%